vitreomacular traction
Recently Published Documents


TOTAL DOCUMENTS

382
(FIVE YEARS 79)

H-INDEX

31
(FIVE YEARS 4)

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Thomas Bertelmann ◽  
Lars Berndzen ◽  
Thomas Raber ◽  
Sebastian Pfeiffer ◽  
Andreas Leha ◽  
...  

AbstractThe primary objective was to create and establish a new formula that predicts the individual probability of macular hole closure for eyes with full thickness macular holes (FTMH) accompanied by vitreomacular traction (VMT) which received enzymatic vitreolysis using intravitreally administered ocriplasmin. The secondary objective was to evaluate the forecast reliability of a previously published formula for VMT resolution in VMT-only eyes (OddsIVO-Success = eIntercept × ORyears × ORln(µm); ProbabilityIVO-Success = OddsIVO-Success/(OddsIVO-Success + 1)) on VMT resolution using the current dataset of eyes with FTMH accompanied by VMT. Retrospective analysis of the OASIS, ORBIT, and INJECT-studies. Patients with FTMH and VMT with complete information (n = 213) were included. The effect of gender, age, FTMH diameter, lens status and the presence of epiretinal membranes (ERM) on FTMH closure was assessed using separate univariate logistic regression analyses. With regard to VMT release separate univariate regression analyses were carried out and results were compared with formerly published data of VMT resolution in eyes with VMT only. Overall, 126 eyes (63%) experienced VMT resolution within 28 days. Younger age (p < 0.0001) and VMT diameter (p = 0.041) had a significant impact on VMT release. Overall, 81 eyes (38%) treated with ocriplasmin showed FTMH closure within 28 days. Univariate analysis of the different predictors analyzed revealed that FTMH diameter < 250 µm had a significant impact on treatment success (p = 0.0495). It was not possible to calculate and establish a new multivariate formula that can predict the individual FTMH closure probability for eyes with FTMHs and VMT. However, the results of VMT release prediction in eyes with FTMHs accompanied by VMT matched the prediction of VMT release in eyes with VMT only when using the previously published formula. All in all, predictors for calculating the individual probability of VMT resolution on the one hand and FTMH closure on the other hand are different suggesting diverse pathophysiological mechanisms.


2021 ◽  
Vol 52 (10) ◽  
pp. 544-550
Author(s):  
Heidi J. Huang ◽  
D. Damla Sevgi ◽  
Sunil K. Srivastava ◽  
Jamie Reese ◽  
Justis P. Ehlers

2021 ◽  
Vol Volume 14 ◽  
pp. 7059-7064
Author(s):  
Lei Shao ◽  
Chuan Zhang ◽  
Li Dong ◽  
Wen Da Zhou ◽  
Rui Heng Zhang ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Josef Guber ◽  
Celine Rusch ◽  
Ivo Guber ◽  
Hendrik P. N. Scholl ◽  
Christophe Valmaggia

AbstractTo evaluate the indications and outcomes of perfluoropropane (C3F8) gas injection for symptomatic vitreomacular traction (VMT). A retrospective analysis of eyes with VMT treated with 0.3 mL of C3F8 gas was performed. Patients were not asked to posture after gas injection. In phakic patients, cataract surgery was performed simultaneously. Patients were examined after one week and one month postoperatively. Twenty-nine consecutive eyes of 26 patients with symptomatic VMT who underwent pneumatic vitreolysis were included. A complete posterior vitreous detachment was achieved in 18 eyes (62.1%) after a single gas injection at the final visit. The rate of posterior vitreous detachment was reduced significantly with the presence of epiretinal membrane (ERM) (p = 0.003). Three eyes formed a macular hole (MH) postoperatively and another eye developed a retinal detachment. Mean visual acuity increased significantly after one month (p < 0.008). Pneumatic vitreolysis is a viable option for treating VMT with few adverse events. Patient with concomitant ERM had a significantly lower success rate.


Reflection ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 25-30
Author(s):  
A.V. Eremina ◽  
◽  
D.V. Chernykh ◽  

Study of the lacrimal fluid (LF) as a constant microenvironment of the anterior part of the eye which is the only atraumatically accessible substrate for the diagnosis and research of ophthalmic diseases, such as vitreomacular traction syndrome (VMTS), diabetic retinopathy (DR), makes it possible to study it using electronic microscopy methods. All studied LF samples contain cells and cell fragments; exosomes which are vesicles (40–100 nm) localized in multivesicular bodies, transmitting signals between cells and carrying markers of many diseases. Analysis of the samples revealed changes in the occurrence of these structures in VMTS and DR in comparison with healthy subjects. In this work, the components of the LF were visualized and their changes were established in DR and VMTS, which proves the value of the LF as a diagnostic substrate and determines the need for further research in order to formulate clear criteria for the diagnosis of these diseases in the early stages. Key words: lacrimal fluid; electronic microscopy; vitreomacular traction syndrome; diabetic retinopathy.


Retina ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Sami Al-Nawaiseh ◽  
Annekatrin Rickmann ◽  
Anna-Maria Seuthe ◽  
Dalia Al-Rimawi ◽  
Boris Viktor Stanzel. ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document